(COVID-19 Version) Global Biologics and Biosimilars Market Status (2015-2019) and Forecast (2020-2025) by Region, Product Type & End-Use

Publisher Name :
Date: 04-Sep-2020
No. of pages: 132

Summary

A biologic is a medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilars are recombinant proteins, or proteins derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or antibodies drugs production by bio-engineered technology, but does not include a vaccine.A biosimilar in this report is a biologic medical product which is copy of an original product that is manufactured by a different company. Biosimilars are officially approved versions of original "innovator" products, and can be manufactured when the original product's patent expires.

The report forecast global Biologics and Biosimilars market to grow to reach xxx Million USD in 2019 with a CAGR of xx% during the period 2020-2025 due to coronavirus situation.

The report offers detailed coverage of Biologics and Biosimilars industry and main market trends with impact of coronavirus. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Biologics and Biosimilars by geography. The report splits the market size, by volume and value, on the basis of application type and geography.

First, this report covers the present status and the future prospects of the global Biologics and Biosimilars market for 2015-2024.

And in this report, we analyze global market from 5 geographies: Asia-Pacific[China, Southeast Asia, India, Japan, Korea, Western Asia], Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland], North America[United States, Canada, Mexico], Middle East & Africa[GCC, North Africa, South Africa], South America[Brazil, Argentina, Columbia, Chile, Peru].

At the same time, we classify Biologics and Biosimilars according to the type, application by geography. More importantly, the report includes major countries market based on the type and application.

Finally, the report provides detailed profile and data information analysis of leading Biologics and Biosimilars company.

Key Content of Chapters as follows (Including and can be customized) :

Part 1: Market Overview, Development, and Segment by Type, Application & Region

Part 2: Company information, Sales, Cost, Margin etc.

Part 3: Global Market by company, Type, Application & Geography

Part 4: Asia-Pacific Market by Type, Application & Geography

Part 5: Europe Market by Type, Application & Geography

Part 6: North America Market by Type, Application & Geography

Part 7: South America Market by Type, Application & Geography

Part 8: Middle East & Africa Market by Type, Application & Geography

Part 9: Market Features

Part 10: Investment Opportunity

Part 11: Conclusion

Market Segment as follows:

By Region

- Asia-Pacific[China, Southeast Asia, India, Japan, Korea, Western Asia]

- Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland]

- North America[United States, Canada, Mexico]

- Middle East & Africa[GCC, North Africa, South Africa]

- South America[Brazil, Argentina, Columbia, Chile, Peru]

Key Companies

- NatureWorks

- Braskem

- BASF

- Arkema

- DuPont

- Novamont

- Corbion

- Metabolix

- PSM

- PolyOne

- Biome Bioplastics

- Biomer

- FKuR

- Trellis Bioplastics

- Kingfa

- Cardia Bioplastics

- Grabio

- MHG

- Myriant

- Mitsubishi

- Zhejiang Hisun Biomaterials

Market by Type

- Bio-PET

- PHA

- Bio-PE

- Starch Blends

- PLA

- Others

Market by Application

- Packing Industry

- Automotive Industry

- Bottles manufacturing

- Others

(COVID-19 Version) Global Biologics and Biosimilars Market Status (2015-2019) and Forecast (2020-2025) by Region, Product Type & End-Use

Table of Contents

Part 1 Market Overview
1.1 Market Definition
1.2 Market Development
1.2.1 Current Situation
1.2.2 Aspects of COVID-19 Impact
1.3 By Type
Table Type of Biologics and Biosimilars
Figure Global Biologics and Biosimilars Market Share by Type in 2019
1.4 By Application
Table Application of Biologics and Biosimilars
Figure Global Biologics and Biosimilars Market Share by Application in 2019
1.5 By Region
Figure Global Biologics and Biosimilars Market Share by Region in 2019
Figure Asia Biologics and Biosimilars Market Share by Region in 2019
Part 2 Key Companies
2.1 NatureWorks
2.1.1 Company Profile
Table NatureWorks Overview List
2.1.2 Products & Services Overview
2.1.3 Sales Data List
Table Biologics and Biosimilars Business Operation of NatureWorks (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
2.2 Braskem
2.3 BASF
2.4 Arkema
2.5 DuPont
2.6 Novamont
2.7 Corbion
2.8 Metabolix
2.9 PSM
2.10 PolyOne
2.11 Biome Bioplastics
2.12 Biomer
2.13 FKuR
2.14 Trellis Bioplastics
2.15 Kingfa
2.16 Cardia Bioplastics
2.17 Grabio
2.18 MHG
2.19 Myriant
2.20 Mitsubishi
2.21 Zhejiang Hisun Biomaterials
Part 3 Global Market Status and Future Forecast
3.1 Global Market by Region
Table Global Biologics and Biosimilars Market by Region, 2015-2019 (Million USD)
Figure Global Biologics and Biosimilars Market Share by Region in 2019 (Million USD)
3.2 Global Market by Company
Table Global Biologics and Biosimilars Market by Company, 2015-2019 (Million USD)
Figure Global Biologics and Biosimilars Market Share by Company in 2019 (Million USD)
3.3 Global Market by Type
Table Global Biologics and Biosimilars Market by Type, 2015-2019 (Million USD)
Figure Global Biologics and Biosimilars Market Share by Type in 2019 (Million USD)
3.4 Global Market by Application
Table Global Biologics and Biosimilars Market by Application, 2015-2019 (Million USD)
Figure Global Biologics and Biosimilars Market Share by Application in 2019 (Million USD)
3.5 Global Market by Forecast
Figure Global Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
Part 4 Asia-Pacific Market Status and Future Forecast
4.1 Asia-Pacific Market by Type
Table Asia-Pacific Biologics and Biosimilars Market by Type, 2015-2019 (Million USD)
Figure Asia-Pacific Biologics and Biosimilars Market Share by Type in 2019 (Million USD)
4.2 Asia-Pacific Market by Application
Table Asia-Pacific Biologics and Biosimilars Market by Application, 2015-2019 (Million USD)
Figure Asia-Pacific Biologics and Biosimilars Market Share by Application in 2019 (Million USD)
4.3 Asia-Pacific Market by Geography
4.3.1 China Market Status and Future Forecast
Figure China Biologics and Biosimilars Market Market Status, 2015-2019 (Million USD)
Figure China Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
4.3.2 Southeast Asia Market Status and Future Forecast
Figure Southeast Asia Biologics and Biosimilars Market Market Status, 2015-2019 (Million USD)
Figure Southeast Asia Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
4.3.3 India Market Status and Future Forecast
Figure India Biologics and Biosimilars Market Market Status, 2015-2019 (Million USD)
Figure India Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
4.3.4 Japan Market Status and Future Forecast
Figure Japan Biologics and Biosimilars Market Market Status, 2015-2019 (Million USD)
Figure Japan Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
4.3.5 Korea Market Status and Future Forecast
Figure Korea Biologics and Biosimilars Market Market Status, 2015-2019 (Million USD)
Figure Korea Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
4.3.6 Oceania Market Status and Future Forecast
Figure Oceania Biologics and Biosimilars Market Market Status, 2015-2019 (Million USD)
Figure Oceania Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
4.4 Asia-Pacific Market by Forecast
Figure Asia-Pacific Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
Part 5 Europe Market Status and Future Forecast
5.1 Europe Market by Type
Table Europe Biologics and Biosimilars Market by Type, 2015-2019 (Million USD)
Figure Europe Biologics and Biosimilars Market Share by Type in 2019 (Million USD)
5.2 Europe Market by Application
Table Europe Biologics and Biosimilars Market by Application, 2015-2019 (Million USD)
Figure Europe Biologics and Biosimilars Market Share by Application in 2019 (Million USD)
5.3 Europe Market by Geography
5.3.1 Germany Market Status and Future Forecast
Figure Germany Biologics and Biosimilars Market Market Status, 2015-2019 (Million USD)
Figure Germany Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
5.3.2 UK Market Status and Future Forecast
Figure UK Biologics and Biosimilars Market Market Status, 2015-2019 (Million USD)
Figure UK Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
5.3.3 France Market Status and Future Forecast
Figure France Biologics and Biosimilars Market Market Status, 2015-2019 (Million USD)
Figure France Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
5.3.4 Italy Market Status and Future Forecast
Figure Italy Biologics and Biosimilars Market Market Status, 2015-2019 (Million USD)
Figure Italy Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
5.3.5 Russia Market Status and Future Forecast
Figure Russia Biologics and Biosimilars Market Market Status, 2015-2019 (Million USD)
Figure Russia Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
5.3.6 Spain Market Status and Future Forecast
Figure Spain Biologics and Biosimilars Market Market Status, 2015-2019 (Million USD)
Figure Spain Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
5.3.6 Netherlands Market Status and Future Forecast
Figure Netherlands Biologics and Biosimilars Market Market Status, 2015-2019 (Million USD)
Figure Netherlands Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
5.3.7 Turkey Market Status and Future Forecast
Figure Turkey Biologics and Biosimilars Market Market Status, 2015-2019 (Million USD)
Figure Turkey Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
5.3.6 Switzerland Market Status and Future Forecast
Figure Switzerland Biologics and Biosimilars Market Market Status, 2015-2019 (Million USD)
Figure Switzerland Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
5.4 Europe Market by Forecast
Figure Europe Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
Part 6 North America Market Status and Future Forecast
6.1 North America Market by Type
Table North America Biologics and Biosimilars Market by Type, 2015-2019 (Million USD)
Figure North America Biologics and Biosimilars Market Share by Type in 2019 (Million USD)
6.2 North America Market by Application
Table North America Biologics and Biosimilars Market by Application, 2015-2019 (Million USD)
Figure North America Biologics and Biosimilars Market Share by Application in 2019 (Million USD)
6.3 North America Market by Geography
6.3.1 United States Market Status and Future Forecast
Figure United States Biologics and Biosimilars Market Market Status, 2015-2019 (Million USD)
Figure United States Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
6.3.2 Canada Market Status and Future Forecast
Figure Canada Biologics and Biosimilars Market Market Status, 2015-2019 (Million USD)
Figure Canada Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
6.3.3 Mexico Market Status and Future Forecast
Figure Mexico Biologics and Biosimilars Market Market Status, 2015-2019 (Million USD)
Figure Mexico Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
6.4 North America Market by Forecast
Figure North America Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
Part 7 South America Market Status and Future Forecast
7.1 South America Market by Type
Table South America Biologics and Biosimilars Market by Type, 2015-2019 (Million USD)
Figure South America Biologics and Biosimilars Market Share by Type in 2019 (Million USD)
7.2 South America Market by Application
Table South America Biologics and Biosimilars Market by Application, 2015-2019 (Million USD)
Figure South America Biologics and Biosimilars Market Share by Application in 2019 (Million USD)
7.3 South America Market by Geography
7.3.1 Brazil Market Status and Future Forecast
Figure Brazil Biologics and Biosimilars Market Market Status, 2015-2019 (Million USD)
Figure Brazil Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
7.3.2 Argentina Market Status and Future Forecast
Figure Argentina Biologics and Biosimilars Market Market Status, 2015-2019 (Million USD)
Figure Argentina Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
7.3.3 Columbia Market Status and Future Forecast
Figure Columbia Biologics and Biosimilars Market Market Status, 2015-2019 (Million USD)
Figure Columbia Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
7.3.4 Chile Market Status and Future Forecast
Figure Chile Biologics and Biosimilars Market Market Status, 2015-2019 (Million USD)
Figure Chile Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
7.3.5 Peru Market Status and Future Forecast
Figure Peru Biologics and Biosimilars Market Market Status, 2015-2019 (Million USD)
Figure Peru Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
7.4 South America Market by Forecast
Figure South America Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
Part 8 Middle East & Africa Market Status and Future Forecast
8.1 Middle East & Africa Market by Type
Table Middle East & Africa Biologics and Biosimilars Market by Type, 2015-2019 (Million USD)
Figure Middle East & Africa Biologics and Biosimilars Market Share by Type in 2019 (Million USD)
8.2 Middle East & Africa Market by Application
Table Middle East & Africa Biologics and Biosimilars Market by Application, 2015-2019 (Million USD)
Figure Middle East & Africa Biologics and Biosimilars Market Share by Application in 2019 (Million USD)
8.3 Middle East & Africa Market by Geography
8.3.1 GCC Market Status and Future Forecast
Figure GCC Biologics and Biosimilars Market Market Status, 2015-2019 (Million USD)
Figure GCC Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
8.3.2 North Africa Market Status and Future Forecast
Figure North Africa Biologics and Biosimilars Market Market Status, 2015-2019 (Million USD)
Figure North Africa Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
8.3.3 South Africa Market Status and Future Forecast
Figure South Africa Biologics and Biosimilars Market Market Status, 2015-2019 (Million USD)
Figure South Africa Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
8.4 Middle East & Africa Market by Forecast
Figure Middle East & Africa Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
Part 9 Market Features
9.1 Product Features
9.2 Price Features
9.3 Channel Features
9.4 Purchasing Features
Part 10 Investment Opportunity
10.1 Regional Investment Opportunity
10.2 Industry Investment Opportunity
PART 11 Coronavirus Impact
11.1 Impact on Industry Upstream
11.2 Impact on Industry Downstream
11.3 Impact on Industry Channels
11.4 Impact on Industry Competition
11.5 Impact on Industry Obtain Employment
Part 12 Conclusion

List of Tables

Table Type of Biologics and Biosimilars
Table Application of Biologics and Biosimilars
Table NatureWorks Overview List
Table Biologics and Biosimilars Business Operation of NatureWorks (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Life & Medical Business Operation of Braskem (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Business Operation of BASF (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Business Operation of Arkema (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table xxx Business Operation of DuPont (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table xx% Business Operation of Novamont (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table 19 Business Operation of Corbion (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table 4 Business Operation of Metabolix (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table 0 Business Operation of PSM (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table 5 Business Operation of PolyOne (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table 2230 Business Operation of Biome Bioplastics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table 2680 Business Operation of Biomer (Sales Revenue, Cost, Gross Margin)
Table 3480 Business Operation of FKuR (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table 112 Business Operation of Trellis Bioplastics (Sales Revenue, Cost, Gross Margin)
Table Business Operation of Kingfa (Sales Revenue, Cost, Gross Margin)
Table A biologic is a medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilars are recombinant proteins, or proteins derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or antibodies drugs production by bio-engineered technology, but does not include a vaccine.A biosimilar in this report is a biologic medical product which is copy of an original product that is manufactured by a different company. Biosimilars are officially approved versions of original "innovator" products, and can be manufactured when the original product's patent expires. Business Operation of Cardia Bioplastics (Sales Revenue, Cost, Gross Margin)
Table Business Operation of Grabio (Sales Revenue, Cost, Gross Margin)
Table Business Operation of MHG (Sales Revenue, Cost, Gross Margin)
Table Business Operation of Myriant (Sales Revenue, Cost, Gross Margin)
Table Business Operation of Mitsubishi (Sales Revenue, Cost, Gross Margin)
Table Business Operation of Zhejiang Hisun Biomaterials (Sales Revenue, Cost, Gross Margin)
Table Global Biologics and Biosimilars Market by Region, 2015-2019 (Million USD)
Table Global Biologics and Biosimilars Market by Company, 2015-2019 (Million USD)
Table Global Biologics and Biosimilars Market by Type, 2015-2019 (Million USD)
Table Global Biologics and Biosimilars Market by Application, 2015-2019 (Million USD)
Table Asia-Pacific Biologics and Biosimilars Market by Type, 2015-2019 (Million USD)
Table Asia-Pacific Biologics and Biosimilars Market by Application, 2015-2019 (Million USD)
Table Europe Biologics and Biosimilars Market by Type, 2015-2019 (Million USD)
Table Europe Biologics and Biosimilars Market by Application, 2015-2019 (Million USD)
Table North America Biologics and Biosimilars Market by Type, 2015-2019 (Million USD)
Table North America Biologics and Biosimilars Market by Application, 2015-2019 (Million USD)
Table South America Biologics and Biosimilars Market by Type, 2015-2019 (Million USD)
Table South America Biologics and Biosimilars Market by Application, 2015-2019 (Million USD)
Table Middle East & Africa Biologics and Biosimilars Market by Type, 2015-2019 (Million USD)
Table Middle East & Africa Biologics and Biosimilars Market by Application, 2015-2019 (Million USD)

List of Figures

Figure Global Biologics and Biosimilars Market Share by Type in 2019
Figure Global Biologics and Biosimilars Market Share by Application in 2019
Figure Global Biologics and Biosimilars Market Share by Region in 2019
Figure Asia Biologics and Biosimilars Market Share by Region in 2019
Figure Global Biologics and Biosimilars Market Share by Region in 2019 (Million USD)
Figure Global Biologics and Biosimilars Market Share by Company in 2019 (Million USD)
Figure Global Biologics and Biosimilars Market Share by Type in 2019 (Million USD)
Figure Global Biologics and Biosimilars Market Share by Application in 2019 (Million USD)
Figure Global Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
Figure Asia-Pacific Biologics and Biosimilars Market Share by Type in 2019 (Million USD)
Figure Asia-Pacific Biologics and Biosimilars Market Share by Application in 2019 (Million USD)
Figure China Biologics and Biosimilars Market Market Status, 2015-2019 (Million USD)
Figure China Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
Figure Southeast Asia Biologics and Biosimilars Market Market Status, 2015-2019 (Million USD)
Figure Southeast Asia Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
Figure India Biologics and Biosimilars Market Market Status, 2015-2019 (Million USD)
Figure India Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
Figure Japan Biologics and Biosimilars Market Market Status, 2015-2019 (Million USD)
Figure Japan Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
Figure Korea Biologics and Biosimilars Market Market Status, 2015-2019 (Million USD)
Figure Korea Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
Figure Oceania Biologics and Biosimilars Market Market Status, 2015-2019 (Million USD)
Figure Oceania Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
Figure Asia-Pacific Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
Figure Europe Biologics and Biosimilars Market Share by Type in 2019 (Million USD)
Figure Europe Biologics and Biosimilars Market Share by Application in 2019 (Million USD)
Figure Germany Biologics and Biosimilars Market Market Status, 2015-2019 (Million USD)
Figure Germany Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
Figure UK Biologics and Biosimilars Market Market Status, 2015-2019 (Million USD)
Figure UK Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
Figure France Biologics and Biosimilars Market Market Status, 2015-2019 (Million USD)
Figure France Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
Figure Italy Biologics and Biosimilars Market Market Status, 2015-2019 (Million USD)
Figure Italy Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
Figure Russia Biologics and Biosimilars Market Market Status, 2015-2019 (Million USD)
Figure Russia Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
Figure Spain Biologics and Biosimilars Market Market Status, 2015-2019 (Million USD)
Figure Spain Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
Figure Netherlands Biologics and Biosimilars Market Market Status, 2015-2019 (Million USD)
Figure Netherlands Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
Figure Turkey Biologics and Biosimilars Market Market Status, 2015-2019 (Million USD)
Figure Turkey Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
Figure Switzerland Biologics and Biosimilars Market Market Status, 2015-2019 (Million USD)
Figure Switzerland Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
Figure Europe Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
Figure North America Biologics and Biosimilars Market Share by Type in 2019 (Million USD)
Figure North America Biologics and Biosimilars Market Share by Application in 2019 (Million USD)
Figure United States Biologics and Biosimilars Market Market Status, 2015-2019 (Million USD)
Figure United States Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
Figure Canada Biologics and Biosimilars Market Market Status, 2015-2019 (Million USD)
Figure Canada Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
Figure Mexico Biologics and Biosimilars Market Market Status, 2015-2019 (Million USD)
Figure Mexico Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
Figure North America Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
Figure South America Biologics and Biosimilars Market Share by Type in 2019 (Million USD)
Figure South America Biologics and Biosimilars Market Share by Application in 2019 (Million USD)
Figure Brazil Biologics and Biosimilars Market Market Status, 2015-2019 (Million USD)
Figure Brazil Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
Figure Argentina Biologics and Biosimilars Market Market Status, 2015-2019 (Million USD)
Figure Argentina Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
Figure Columbia Biologics and Biosimilars Market Market Status, 2015-2019 (Million USD)
Figure Columbia Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
Figure Chile Biologics and Biosimilars Market Market Status, 2015-2019 (Million USD)
Figure Chile Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
Figure Peru Biologics and Biosimilars Market Market Status, 2015-2019 (Million USD)
Figure Peru Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
Figure South America Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
Figure Middle East & Africa Biologics and Biosimilars Market Share by Type in 2019 (Million USD)
Figure Middle East & Africa Biologics and Biosimilars Market Share by Application in 2019 (Million USD)
Figure GCC Biologics and Biosimilars Market Market Status, 2015-2019 (Million USD)
Figure GCC Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
Figure North Africa Biologics and Biosimilars Market Market Status, 2015-2019 (Million USD)
Figure North Africa Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
Figure South Africa Biologics and Biosimilars Market Market Status, 2015-2019 (Million USD)
Figure South Africa Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
Figure Middle East & Africa Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
  • Global Biologics and Biosimilars Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 147
    According to our LPI (LP Information) latest study, the global Biologics and Biosimilars market size was valued at US$ 458090 million in 2023. With growing demand in downstream market, the Biologics and Biosimilars is forecast to a readjusted size of US$ 837640 million by 2030 with a CAGR of 9.0% during review period. The research report highlights the growth potential of the global Biologics and Biosimilars market. Biologics and Biosimilars are expected to show stable growth in the futu......
  • Global Biosimilar Drug Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 94
    According to our LPI (LP Information) latest study, the global Biosimilar Drug market size was valued at US$ million in 2023. With growing demand in downstream market, the Biosimilar Drug is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Biosimilar Drug market. Biosimilar Drug are expected to show stable growth in the future market. However, product differentiation, reducing cost......
  • Global Biologics and Biosimilars Market 2024 by Company, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 147
    According to our (Global Info Research) latest study, the global Biologics and Biosimilars market size was valued at USD 481830 million in 2023 and is forecast to a readjusted size of USD 842330 million by 2030 with a CAGR of 8.3% during review period. Biologics are very specific, highly effective medicines made in living cells, and historically this was often an animal. Biologics include hormones, cytokines, growth factors, vaccines, gene and cellular therapies, fusion proteins, insulin......
  • Global Biosimilars Market Research Report 2023, Forecast to 2028
    Published: 27-Dec-2023        Price: US 2680 Onwards        Pages: 167
    A biosimilar is a biologic medical product (also known as biologic) highly similar to another already approved biological medicine (the 'reference medicine'). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technol......
  • Global Biosimilars Professional Survey Report 2023, Forecast to 2028
    Published: 27-Dec-2023        Price: US 3280 Onwards        Pages: 133
    A biosimilar is a biologic medical product (also known as biologic) highly similar to another already approved biological medicine (the 'reference medicine'). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technol......
  • Global Biosimilars Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 07-Dec-2023        Price: US 3380 Onwards        Pages: 106
    Market Overview of Global Biosimilars market: According to our latest research, the global Biosimilars market looks promising in the next 5 years. As of 2022, the global Biosimilars market was estimated at USD 8203.97 million, and it's anticipated to reach USD 40650.01 million in 2028, with a CAGR of 30.57% during the forecast years. A biosimilar product is a biologic product that is approved based on demonstrating that it is highly similar to an FDA?approved biologic product......
  • Global Biologics and Biosimilars Professional Survey Report 2023, Forecast to 2028
    Published: 24-Nov-2023        Price: US 3280 Onwards        Pages: 134
    Biologics include a wide variety of products such as gene and cell therapies, therapeutic proteins, monoclonal antibodies, and vaccines. Biosimilars are highly similar to the reference product in terms of safety, purity and potency, but may have minor differences in clinically inactive components. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) da......
  • Global Biologics and Biosimilars Market Research Report 2023, Forecast to 2028
    Published: 24-Nov-2023        Price: US 2680 Onwards        Pages: 160
    Biologics include a wide variety of products such as gene and cell therapies, therapeutic proteins, monoclonal antibodies, and vaccines. Biosimilars are highly similar to the reference product in terms of safety, purity and potency, but may have minor differences in clinically inactive components. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) da......
  • Global Biosimilar Monoclonal Antibodies Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 16-Nov-2023        Price: US 3380 Onwards        Pages: 103
    Market Overview of Global Biosimilar Monoclonal Antibodies market: According to our latest research, the global Biosimilar Monoclonal Antibodies market looks promising in the next 5 years. As of 2022, the global Biosimilar Monoclonal Antibodies market was estimated at USD 5156.19 million, and it's anticipated to reach USD 14274.14 million in 2028, with a CAGR of 18.5% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs